Biopharm SA
16.0 FTEBiopharm reported revenue of €10.3m for the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026), with 16 full-time equivalents.
The score of Biopharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +28 % Equity -2 % Total assets +2 % Headcount (avg FTE) -6 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biopharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €10.3m | ||||
| Net result | −43,547 € | ||||
| Equity | €5.37m | ||||
| Cash | 8,070 € | ||||
| EBITDA | 683,207 € | ||||
| Total assets | €12.0m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 31 Mar 2024
- Year ended 30 Sep 2022filed on 30 Mar 2023
- Year ended 30 Sep 2021filed on 13 Apr 2022
Biopharm's financial analysis
- Solvency44.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biopharm
Biopharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0438.547.292
- VAT number
- BE0438547292
- Peppol
- Registered · 0208:0438547292 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Oct 1989
- Registered office
- 3070 Kortenberg
- Size
- Small · 16.0 FTE
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Biopharm (SA) has been based in Kortenberg since 1989, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of €10.3m, a net loss of 43,547 € and equity of €5.37m. With 16.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 44.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biopharm
Companies in the same business, of comparable size and area, outside its group.
- MOES Retail sale of pharmaceutical products Heers · balance sheet €16.4m
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Pharmacie Houba Retail sale of pharmaceutical products Brussels · balance sheet €8.75m
- Panorama Operations Retail sale of pharmaceutical products Lummen · balance sheet €9.73m
- Vooruit NR. 1 Retail sale of pharmaceutical products Ghent · balance sheet €18.3m
- AFS Retail sale of pharmaceutical products Antwerp · balance sheet €22.0m
- Oxycure Retail sale of pharmaceutical products Fernelmont · balance sheet €11.2m
- Inveda Retail sale of pharmaceutical products Ostend · balance sheet €13.6m
Frequently asked questions about Biopharm
What is the revenue of Biopharm?
According to the 2025 annual accounts filed with the NBB, the revenue of Biopharm amounts to 10,327,378 €.
What is the VAT number of Biopharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0438547292 for Biopharm, if the company is VAT-registered. Its company number (CBE) is 0438.547.292.
Where is the registered office of Biopharm?
According to the CBE register, the registered office of Biopharm is in 3070 Kortenberg.
What is the equity of Biopharm?
At the close of the 2025 financial year, the equity of Biopharm amounts to 5,369,834 €, a solvency of 44.7% of total assets.
How many people work at Biopharm?
16.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biopharm?
The register lists 4 active mandates at Biopharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biopharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →